Therapeutic potential of sunitinib in the treatment of malignant islet cell tumor
10.3760/cma.j.issn.1000-6699.2011.07.022
- VernacularTitle:舒尼替尼治疗恶性胰岛细胞瘤疗效初探
- Author:
Shaoting WANG
;
Naishi LI
- Publication Type:Journal Article
- Keywords:
Sunitinib malate;
Malignant islet cell tumor
- From:
Chinese Journal of Endocrinology and Metabolism
2011;27(7):618-620
- CountryChina
- Language:Chinese
-
Abstract:
Malignant islet cell tumor, a rare type of neuroendocrine carcinoma, biologically behaves in an aggressive way and is difficulty to be treated. Sunitinib malate, a novel tyrosine kinase inhibitor, demonstrates a high efficacy in treating malignant islet cell tumor as shown by promising results in recent trials.
